It is interesting to note that the effect of hirugen on exosite 1 is similar to that of soluble thrombomodulin, which is currently undergoing clinical trials for the treatment of sepsis and disseminated intravascular coagulation (44). This evidence concerns the gene THBD and Sepsis.